MindMics focuses on developing a health monitoring platform using infrasonic hemodynography (IH), a technology that analyzes low-frequency acoustical vibrations in the ear canal. The technology can be embedded in earbuds and hearing aids to enable the capture of subtle sound deviations to create a detailed picture of an individual's health.
In May 2023, the company launched the MindMics Heart Health System in a limited release to track heart rate and heart rate variability in real-time using its IH technology. The company claims the system delivers results with a 99% correlation to a regular ECG.
The company operates primarily with a D2C business model, offering its health monitoring platform and earbuds on a subscription basis. Additionally, as of January 2024, the company was developing a B2B2C model to integrate the MindMics system into clinical settings.
Key customers and partnerships
The company had several key partnerships to develop and clinically validate its IH technology, including partnerships with Prisma Health (March 2020) and Scripps Health (December 2021).
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.